Papers - SUZUKI Hiroyuki
-
Development of targeted therapy and immunotherapy for treatment of small cell lung cancer.
Motonobu Saito, Kouya Shiraishi, Akiteru Goto, Hiroyuki Suzuki, Takashi Kohno, Koji Kono.
Japanese Journal of Clinical Oncology 48 ( 7 ) 603 - 608 2018.7（ ISSN:14653621 ）
-
編集後記
鈴木弘行
肺癌 58 ( 3 ) 241 2018.6（ ISSN:03869628 ）
-
Quantitative T-cell repertoire analysis of peripheral blood mononuclear cells from lung cancer patients following long-term cancer peptide vaccination.
Kazuyoshi Takeda, Kazutaka Kitaura, Ryuji Suzuki, Yuki Owada, Satoshi Muto, Naoyuki Okabe, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Takuya Tsunoda, Ko Okumura, Hiroyuki Suzuki.
Cancer Immunology, Immunotherapy 67 ( 6 ) 949 - 964 2018.6（ ISSN:03407004 ）
-
Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.
Kazuki Hayasaka, Satoshi Shiono, Yuki Matsumura, Naoki Yanagawa, Hiroyuki Suzuki, Jiro Abe, Motoyasu Sagawa, Akira Sakurada, Masato Katahira, Satomi Takahashi, Makoto Endoh, Yoshinori Okada.
Annals of Thoracic Surgery 105 ( 6 ) 1648 - 1654 2018.6（ ISSN:00034975 ）
-
Expression of liver X receptors in normal and refractory carcinoma tissues of the human lung and pancreas.
Korehito Kashiwagi, Mai Yanagida, Daiki Matsui, Mizuko Tanaka, Kotaro Sugimoto, Honglei Chen, Naoki Ichikawa-Tomikawa, Shigeru Marubashi, Hiroyuki Suzuki, Hideki Chiba.
Histology and Histopathology 33 ( 5 ) 497 - 505 2018.5（ ISSN:02133911 ）
-
肺癌治療の現状と展望
鈴木弘行
安達医師会報 ( 57 ) 41 2018.5
-
Comparison of surgical outcomes after pneumonectomy and pulmonary function-preserving surgery for non-small cell lung cancer.
Mitsunori Higuchi, Hironori Takagi, Yuki Ozaki, Takuya Inoue, Yuzuru Watanabe, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Yutaka Shio, Hiroyuki Suzuki.
Fukushima Journal of Medical Science 64 ( 1 ) 30 - 37 2018.4（ ISSN:00162590 ）
-
A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
Motoyasu Sagawa, Hiroyuki Oizumi, Hiroyuki Suzuki, Hidetaka Uramoto, Katsuo Usuda, Akira Sakurada, Masayuki Chida, Satoshi Shiono, Jiro Abe, Tohru Hasumi , Masami Sato, Nobuyuki Sato, Jotaro Shibuya, Hiroyuki Deguchi, Yoshinori Okada.
European Journal of Cardio-thoracic Surgery 53 ( 4 ) 849 - 856 2018.4（ ISSN:10107940 ）
-
Garcin syndrome caused by sphenoid bone metastasis of lung cancer: a case study.
Satoshi Fukai, Naoyuki Okabe, Hayato Mine, Hironori Takagi, Hiroyuki Suzuki.
World Journal of Surgical Oncology 16 ( 1 ) 46 2018.3（ ISSN:14777819 ）
-
肺転移を伴わない癌性胸膜炎のみを認めた転移性腎細胞癌の1例
渡邊 譲, 管野隆三, 鈴木弘行
日本呼吸器外科学会雑誌 32 ( 2 ) 147 - 152 2018.3（ ISSN:09190945 ）
-
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.
Takumi Yamaura, Junji Ezaki, Naoyuki Okabe, Hironori Takagi, Yuki Ozaki, Takuya Inoue, Yuzuru Watanabe, Mitsuro Fukuhara, Satoshi Muto, Yuki Matsumura, Takeo Hasegawa, Mika Hoshino, Jun Osugi, Yutaka Shio, Satoshi Waguri, Hirosumi Tamura, Jun-ichi Imai, Emi Ito, Yuka Yanagisawa, Reiko Honma, Shinya Watanabe, Hiroyuki Suzuki.
Oncology Letters 15 ( 2 ) 1549 - 1558 2018.2（ ISSN:17921074 ）
-
Identification of candidate responders for anti-PD-L1/PD-1 immunotherapy, Rova-T therapy, or EZH2 inhibitory therapy in small-cell lung cancer.
Motonobu Saito, Katsuharu Saito, Kouya Shiraishi, Daichi Maeda, Hiroyuki Suzuki, Yoshihiro Minamiya, Koji Kono, Takashi Kohno, Akiteru Goto.
Molecular and Clinical Oncology 8 ( 2 ) 310 - 314 2018.2（ ISSN:20499450 ）
-
特集 腫瘍免疫研究の最前線 非小細胞肺がんに対するがん免疫療法の進歩
武藤哲史, 鈴木弘行
癌と化学療法 45 ( 2 ) 212 - 216 2018.2（ ISSN:03850684 ）
-
癌免疫 カンファレンスルーム 肺癌から学ぶこと―ガイドラインの変更―
尾崎有紀, 鈴木弘行
消化器外科 41 ( 2 ) 193 - 197 2018.2（ ISSN:03872645 ）
-
Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy.
Motonobu Saito, Hiroyuki Suzuki, Koji Kono, Seiichi Takenoshita, Takashi Kohno
Surgery Today 48 ( 1 ) 1 - 8 2018.1（ ISSN:09411291 ）
-
Matched-pair analysis of a multi-institutional cohort reveals that epidermal growth factor receptor mutation is not a risk factor for postoperative recurrence of lung adenocarcinoma.
Yuki Matsumura, Hiroyuki Suzuki, Tetsuya Ohira, Satoshi Shiono, Jiro Abe, Motoyasu Sagawa, Akira Sakurada, Masato Katahira, Yuichiro Machida, Satomi Takahashi, Yoshinori Okada
Lung Cancer 114 23 - 30 2017.12（ ISSN:01695002 ）
-
Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.
Yuki Matsumura, Yuki Owada, Takuya Inoue, Yuzuru Watanabe, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Takeo Hasegawa, Mika Hoshino, Jun Osugi, Mitsunori Higuchi, Hiroyuki Suzuki
Interactive CardioVascular and Thoracic Surgery 25 ( 5 ) 690 - 695 2017.11（ ISSN:15699293 ）
-
Efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.
Takuya Inoue, Hironori Takagi, Yuki Owada, Yuzuru Watanabe, Takumi Yamaura, Mitsuro Fukuhara, Satoshi Muto, Naoyuki Okabe, Yuki Matsumura, Takeo Hasegawa, Jun Osugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio, Hiroshi Yokouchi, Kenya Kanazawa, Katsuya Ohbuchi, Takahisa Fukushima, Mitsuru Munakata, Hiroyuki Suzuki
Trials 18 ( 1 ) 485 2017.10（ ISSN:17456215 ）
-
Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma.
Naoyuki Okabe, Hironori Takagi, Hayato Mine, Satoshi Fukai, Hiroyuki Minemura, Hiroyuki Suzuki
Journal of Thoracic Oncology 12 ( 10 ) e167 - e169 2017.10（ ISSN:15560864 ）
-
特別企画(3) 若き外科医からの提言―わたしたちの将来の外科医療を見据えて― 5. 新米外科教授からの提言 医学生教育, 外科専門医研修に主眼をおいた外科学講座再編―福島の新たな挑戦―.
木村 隆, 鈴木眞一, 河野浩二, 丸橋 繁, 鈴木弘行, 大竹 徹, 田中秀明, 横山 斉, 後藤満一, 竹之下誠一.
日本外科学会雑誌 118 ( 5 ) 593 - 596 2017.9（ ISSN:03014894 ）